These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 10604525

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Adenovirus-mediated kallikrein gene delivery reverses salt-induced renal injury in Dahl salt-sensitive rats.
    Chao J, Zhang JJ, Lin KF, Chao L.
    Kidney Int; 1998 Oct; 54(4):1250-60. PubMed ID: 9767541
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Kallikrein gene delivery attenuates hypertension and cardiac hypertrophy and enhances renal function in Goldblatt hypertensive rats.
    Yayama K, Wang C, Chao L, Chao J.
    Hypertension; 1998 May; 31(5):1104-10. PubMed ID: 9576121
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Tissue kallikrein attenuates salt-induced renal fibrosis by inhibition of oxidative stress.
    Zhang JJ, Bledsoe G, Kato K, Chao L, Chao J.
    Kidney Int; 2004 Aug; 66(2):722-32. PubMed ID: 15253727
    [Abstract] [Full Text] [Related]

  • 12. Human kallikrein gene delivery protects against gentamycin-induced nephrotoxicity in rats.
    Murakami H, Yayama K, Chao L, Chao J.
    Kidney Int; 1998 May; 53(5):1305-13. PubMed ID: 9573546
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Experimental kallikrein gene therapy in hypertension, cardiovascular and renal diseases.
    Chao J, Chao L.
    Pharmacol Res; 1997 Jun; 35(6):517-22. PubMed ID: 9356201
    [Abstract] [Full Text] [Related]

  • 16. Reversal of renal fibrosis, inflammation, and glomerular hypertrophy by kallikrein gene delivery.
    Bledsoe G, Shen B, Yao Y, Zhang JJ, Chao L, Chao J.
    Hum Gene Ther; 2006 May; 17(5):545-55. PubMed ID: 16716111
    [Abstract] [Full Text] [Related]

  • 17. Effects of alpha-lipoic acid on deoxycorticosterone acetate-salt-induced hypertension in rats.
    Takaoka M, Kobayashi Y, Yuba M, Ohkita M, Matsumura Y.
    Eur J Pharmacol; 2001 Jul 20; 424(2):121-9. PubMed ID: 11476758
    [Abstract] [Full Text] [Related]

  • 18. Human adrenomedullin gene delivery protects against cardiovascular remodeling and renal injury.
    Chao J, Kato K, Zhang JJ, Dobrzynski E, Wang C, Agata J, Chao L.
    Peptides; 2001 Nov 20; 22(11):1731-7. PubMed ID: 11754958
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Atrial natriuretic peptide gene delivery attenuates hypertension, cardiac hypertrophy, and renal injury in salt-sensitive rats.
    Lin KF, Chao J, Chao L.
    Hum Gene Ther; 1998 Jul 01; 9(10):1429-38. PubMed ID: 9681414
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.